Statements (63)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
company
|
| gptkbp:acquisition |
Acquired by a larger biotech firm in 2020
|
| gptkbp:awards |
Best_Biotech_Company_2019
|
| gptkbp:certifications |
ISO_9001_certified
|
| gptkbp:challenges |
faces regulatory challenges
|
| gptkbp:classification |
utilizes bioinformatics in research
|
| gptkbp:clinicalTrials |
conducts clinical research studies
conducts clinical trials for new therapies contributes to clinical guidelines develops clinical applications for genetic testing |
| gptkbp:collaborations |
engages in collaborative research projects
forms research collaborations with other firms works with pharmaceutical companies |
| gptkbp:community |
engages in community outreach programs
|
| gptkbp:community_service |
offers patient support services
provides innovative healthcare solutions researches biomarkers for diseases |
| gptkbp:competitors |
conducts market research for new products
|
| gptkbp:conference |
participates in biotech conferences
|
| gptkbp:customerBase |
serves hospitals and clinics
|
| gptkbp:employees |
over 200
|
| gptkbp:feedback |
focuses on improving patient outcomes.
|
| gptkbp:focus |
personalized medicine
|
| gptkbp:founded |
1998
|
| gptkbp:founder |
gptkb:Dr._John_Cooke
|
| gptkbp:funding |
receives grants for research projects
|
| gptkbp:future_plans |
plans to expand into new markets
|
| gptkbp:headquarters |
gptkb:United_Kingdom
|
| gptkbp:healthcare |
provides patient education resources
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cooke Group
|
| gptkbp:impact |
aims to have a positive impact on healthcare
|
| gptkbp:industry |
biotechnology
|
| gptkbp:innovation |
focuses on innovative solutions
|
| gptkbp:investmentFocus |
receives venture capital funding
|
| gptkbp:leadership |
led by a team of experts
|
| gptkbp:location |
gptkb:Cambridge,_UK
|
| gptkbp:market |
global market
|
| gptkbp:mission |
improve patient outcomes through innovation
|
| gptkbp:network |
actively networks with industry leaders
part of a global biotech network |
| gptkbp:outcome |
aims to improve clinical outcomes
|
| gptkbp:partnerships |
collaborates with various research institutions
has strategic partnerships with universities |
| gptkbp:philosophy |
believes in patient-centered care
|
| gptkbp:products |
genetic testing
|
| gptkbp:publications |
publishes research in scientific journals
|
| gptkbp:regulates |
complies_with_FDA_regulations
|
| gptkbp:research |
conducts clinical trials
|
| gptkbp:research_areas |
focuses on oncology and rare diseases
|
| gptkbp:revenue |
estimated at $50 million annually
|
| gptkbp:screenings |
conducts_Phase_I,_II,_and_III_clinical_trials
|
| gptkbp:services |
laboratory services
|
| gptkbp:social_responsibility |
engages in social responsibility initiatives
|
| gptkbp:subsidiary |
gptkb:Cooke_Diagnostics
|
| gptkbp:supportRole |
has a scientific advisory board
|
| gptkbp:sustainability |
committed to sustainable practices
|
| gptkbp:technology |
next-generation sequencing
involved in technology transfer initiatives develops proprietary technology invests in technology advancements |
| gptkbp:type |
utilizes big data analytics
|
| gptkbp:vision |
to be a leader in genetic testing
|
| gptkbp:website |
www.cookegroup.com
|